Condition
Age-related Volume Deficit in the Mid-face
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06984419Not ApplicableCompleted
Clinical Investigation of the Medical Device "Alexa Volume" for Correction of Midface Volume Loss
NCT04892407Not ApplicableUnknownPrimary
Algeness DF 3.5% Compared to Voluma in Volume Deficit in Mid-face
NCT03438266Not ApplicableCompletedPrimary
A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
NCT01559064CompletedPrimary
The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face
Showing all 4 trials